CoChat

Reduced Spinophilin But Not Microtubule-Associated Protein 2 Expression in the Hippocampal Formation in Schizophrenia and Mood Disorders: Molecular Evidence for a Pathology of Dendritic Spines

Law, Amanda J., Weickert, Cynthia Shannon, Hyde, Thomas M., Kleinman, Joel E., Harrison, Paul J. · 2004 · American Journal of Psychiatry
Cited by 149

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Aberrant synaptic connectivity may underlie the involvement of the hippocampus in schizophrenia. There is reasonable neuropathological evidence for a presynaptic pathology but few studies of the postsynaptic component. This study tested the hypothesis that hippocampal dendritic pathology is also present in schizophrenia. METHOD: Using in situ hybridization in sections of hippocampal formation from 10 patients with schizophrenia, 10 patients with mood disorders (three with bipolar disorder and seven with major depression), and 10 healthy comparison subjects, the authors examined the expression of two important dendritic genes: spinophilin, which serves as a marker of dendritic spines, and microtubule-associated protein 2 (MAP2), an overall dendritic marker. RESULTS: The patients with schizophrenia had lower levels of spinophilin mRNA in CA4 (hilus), CA3, the subiculum, and the entorhinal cortex than did the normal comparison subjects. The mood disorder group showed similar differences from the comparison group. MAP2 and cyclophilin mRNA did not differ between the groups in any subfield. CONCLUSIONS: Decreased spinophilin but unchanged MAP2 expression provides molecular evidence for a hippocampal dendritic pathology in schizophrenia that preferentially affects the spines. As spines are the target of most glutamatergic synapses, the data extend the evidence that excitatory synapses are particularly affected. Similar dendritic spine pathology may also occur in mood disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1176/ajp.161.10.1848

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 46

  1. Stevens JR: Abnormal reinnervation as a basis for schizophrenia: a hypothesis. Arch Gen Psychiatry 1992; 49:238–243 · DOI · Paper page
  2. McGlashan TH, Hoffman RE: Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch Gen Psychiatry 2000; 57:637–648 · DOI · Paper page
  3. Costa E, Davis J, Grayson DR, Guidotti A, Pappas GD, Pesold C: Dendritic spine hypoplasticity and downregulation of reelin and GABAergic tone in schizophrenia vulnerability. Neurobiol Dis 2001; 8:723–742 · DOI · Paper page
  4. Mirnics K, Middleton FA, Lewis DA, Levitt P: Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse. Trends Neurosci 2001; 24:479–486 · DOI · Paper page
  5. Moises HW, Zoega T, Gottesman II: The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia. BMC Psychiatry 2002; 2:8 · DOI · Paper page
  6. Frankle WG, Lerma J, Laruelle M: The synaptic hypothesis of schizophrenia. Neuron 2003; 39:205–216 · DOI · Paper page
  7. Harrison PJ, Owen MJ: Genes for schizophrenia? recent findings and their pathophysiological implications. Lancet 2003; 361:417–419 · DOI · Paper page
  8. Eastwood SL, Cairns NJ, Harrison PJ: Synaptophysin gene expression in schizophrenia: investigations of synaptic pathology in the cerebral cortex. Br J Psychiatry 2000; 176:236–242 · DOI · Paper page
  9. Eastwood SL, Burnet PWJ, Harrison PJ: Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia. Neuroscience 1995; 66:309–319 · DOI · Paper page
  10. Eastwood SL, Harrison PJ: Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography. Neuroscience 1995; 69:339–343 · DOI · Paper page
  11. Eastwood SL, Harrison PJ: Detection and quantification of hippocampal synaptophysin messenger RNA in schizophrenia using autoclaved, formalin-fixed, paraffin wax-embedded sections. Neuroscience 1999; 93:99–106 · DOI
  12. Webster MJ, Weickert CS, Herman MM, Hyde TM, Kleinman JE: Synaptophysin and GAP-43 mRNA levels in the hippocampus of subjects with schizophrenia. Schizophr Res 2001; 49:89–98 · DOI
  13. Harrison PJ, Eastwood SL: Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia. Hippocampus 2001; 11:508–519 · DOI · Paper page
  14. Harrison PJ, Eastwood SL: Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia. Lancet 1998; 352:1669–1673 · DOI
  15. Harrison PJ, Law AJ, Eastwood SL: Glutamate receptors and transporters in the hippocampus in schizophrenia. Ann NY Acad Sci USA 2003; 1003:94–101 · DOI · Paper page
  16. Weinberger DR: Cell biology of the hippocampal formation in schizophrenia. Biol Psychiatry 1999; 45:395–402 · DOI · Paper page
  17. Arnold SE, Lee VM, Gur RE, Trojanowski JQ: Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia. Proc Natl Acad Sci USA 1991; 88:10850–10854 · DOI · Paper page
  18. Cotter D, Kerwin R, Doshi B, Martin CS, Everall IP: Alterations in hippocampal non-phosphorylated MAP2 protein expression in schizophrenia. Brain Res 1997; 765:238–246 · DOI
  19. Cotter D, Wilson S, Roberts E, Kerwin R, Everall IP: Increased dendritic MAP2 expression in the hippocampus in schizophrenia. Schizophr Res 2000; 41:313–323 · DOI
  20. Allen PB, Ouimet CC, Greengard P: Spinophilin, a novel protein phosphatase 1 binding protein localized to dendritic spines. Proc Natl Acad Sci USA 1997; 94:9956–9961 · DOI · Paper page
  21. Harrison PJ: The neuropathology of primary mood disorder. Brain 2002; 125:1428–1449 · DOI · Paper page
  22. Albala JS, Kalcheva N, Shafit-Zagardo B: Characterization of the transcripts encoding two isoforms of human microtubule-associated protein-2 (MAP-2). Gene 1993; 136:377–378 · DOI
  23. Webster MJ, Weickert CS, Herman MM, Kleinman JE: BDNF mRNA expression during postnatal development, maturation and aging of the human prefrontal cortex. Brain Res Dev Brain Res 2002; 139:139–150 · DOI · Paper page
  24. Law AJ, Deakin JF: Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses. Neuroreport 2001; 12:2971–2974 · DOI · Paper page
  25. Law AJ, Hutchinson LJ, Burnet PWJ, Harrison PJ: Antipsychotics increase microtubule-associated protein 2 mRNA but not spinophilin mRNA in the rat hippocampus and cortex. J Neurosci Res 2004; 76:376–382 · DOI
  26. Tucker RP, Garner CC, Matus A: In situ localization of microtubule-associated protein mRNA in the developing and adult rat brain. Neuron 1989; 2:1245–1256 · DOI · Paper page
  27. Steward O, Wallace CS: mRNA distribution within dendrites: relationship to afferent innervation. J Neurobiol 1995; 26:447–449 · DOI
  28. Amateau SK, McCarthy MM: A novel mechanism of dendritic spine plasticity involving estradiol induction of prostaglandin-E2. J Neurosci 2002; 22:8586–8596 · DOI · Paper page
  29. Represa A, Pollard H, Moreau J, Ghilini G, Khrestchatisky M, Ben Ari Y: Mossy fiber sprouting in epileptic rats is associated with a transient increased expression of alpha-tubulin. Neurosci Lett 1993; 156:149–152 · doi:10.1016/0304-3940(93)90460-3
  30. Pollard H, Khrestchatisky M, Moreau J, Ben Ari Y, Represa A: Correlation between reactive sprouting and microtubule protein expression in epileptic hippocampus. Neuroscience 1994; 61:773–787 · DOI
  31. Montgomery MM, Dean AF, Taffs F, Stott EJ, Lantos PL, Luthert PJ: Progressive dendritic pathology in cynomolgus macaques infected with simian immunodeficiency virus. Neuropathol Appl Neurobiol 1999; 25:11–19 · DOI
  32. Hering H, Sheng M: Dendritic spines: structure, dynamics and regulation. Nat Rev Neurosci 2001; 2:880–888 · DOI · Paper page
  33. Feng J, Yan Z, Ferreira A, Tomizawa K, Liauw JA, Zhuo M, Allen PB, Ouimet CC, Greengard P: Spinophilin regulates the formation and function of dendritic spines. Proc Natl Acad Sci USA 2000; 97:9287–9292 · DOI · Paper page
  34. Miwa C, Ueki A, Shinjo H, Simode H, Morita Y: Long-term synaptic alteration in the rat hippocampal CA3 field following an entorhinal cortex lesion. Psychiatry Clin Neurosci 2001; 55:573–578 · DOI
  35. Tsai G, Passani LA, Slusher BS, Carter R, Baer L, Kleinman JE, Coyle JT: Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch Gen Psychiatry 1995; 52:829–836 · DOI · Paper page
  36. Tamminga C: Glutamatergic aspects of schizophrenia. Br J Psychiatry Suppl 1999; 37:12–15 · DOI
  37. Passafaro M, Nakagawa T, Sala C, Sheng M: Induction of dendritic spines by an extracellular domain of AMPA receptor subunit GluR2. Nature 2003; 424:677–681 · DOI · Paper page
  38. Eastwood SL, McDonald B, Burnet PW, Beckwith JP, Kerwin RW, Harrison PJ: Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia. Brain Res Mol Brain Res 1995; 29:211–223 · DOI · Paper page
  39. Eastwood SL, Kerwin RW, Harrison PJ: Immunoautoradiographic evidence for a loss of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate-preferring non-N-methyl-D-aspartate glutamate receptors within the medial temporal lobe in schizophrenia. Biol Psychiatry 1997; 41:636–643 · DOI
  40. Robinson TE, Gorny G, Mitton E, Kolb B: Cocaine self-administration alters the morphology of dendrites and dendritic spines in the nucleus accumbens and neocortex. Synapse 2001; 39:257–266 · DOI · Paper page
  41. Norrholm SD, Ouimet CC: Altered dendritic spine density in animal models of depression and in response to antidepressant treatment. Synapse 2001; 42:151–163 · DOI · Paper page
  42. Schwab C, Bondada V, Sparks DL, Cahan LD, Geddes JW: Postmortem changes in the levels and localization of microtubule-associated proteins (tau, MAP2 and MAP1B) in the rat and human hippocampus. Hippocampus 1994; 4:210–225 · DOI · Paper page
  43. Eastwood SL, Heffernan J, Harrison PJ: Chronic haloperidol treatment differentially affects the expression of synaptic and neuronal plasticity-associated genes. Mol Psychiatry 1997; 2:322–329 · DOI
  44. Pei Q, Burnet PJ, Zetterstrom TS: Changes in mRNA abundance of microtubule-associated proteins in the rat brain following electroconvulsive shock. Neuroreport 1998; 9:391–394 · DOI
  45. Garey LJ, Ong WY, Patel TS, Kanani M, Davis A, Mortimer AM, Barnes TR, Hirsch SR: Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J Neurol Neurosurg Psychiatry 1998; 65:446–453 · DOI · Paper page
  46. Broadbelt K, Byne W, Jones LB: Evidence for a decrease in basilar dendrites of pyramidal cells in schizophrenic medial prefrontal cortex. Schizophr Res 2002; 58:75–81 · DOI · Paper page

Cited by

See all 149

Metadata

Authors
Law, A. J., Weickert, C. S., Hyde, T. M., Kleinman, J. E., & Harrison, P. J.
Venue
American Journal of Psychiatry
Published
2004-10-01
Volume
161
Issue
10
Pages
1848-1855
ISSN
  • 0002-953X (ISSN-L)
  • 1535-7228
OpenAlex
W1885585690
Cited by
149
References
12
FWCI
5.60
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Reduced Spinophilin But Not Microtubule-Associated Protein 2 Expression in the Hippocampal Formation in Schizophrenia and Mood Disorders: Molecular Evidence for a Pathology of Dendritic Spines. https://app.cochat.ai/papers/10.1176/ajp.161.10.1848
The paper
Law, A. J., Weickert, C. S., Hyde, T. M., Kleinman, J. E., & Harrison, P. J. (2004). Reduced Spinophilin But Not Microtubule-Associated Protein 2 Expression in the Hippocampal Formation in Schizophrenia and Mood Disorders: Molecular Evidence for a Pathology of Dendritic Spines. American Journal of Psychiatry. https://doi.org/10.1176/ajp.161.10.1848

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.